Clinical Trials Sponsored by Danish Oncological Lung Cancer Group

Total 202 results

Danish Oncological Lung Cancer Group

Terminated

Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED)

Small Cell Lung Cancer | Extensive Disease | First-Line

Denmark
Rigshospitalet, Denmark
Danish Lung Cancer Group; Danish Comprehensive Cancer Center

Active, not recruiting

Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy (SUPE_R)

Carcinoma, Non-Small-Cell Lung

Denmark
Spanish Lung Cancer Group

Recruiting

Thoracic Tumours Register (RTT)

Thoracic Tumors

Spain
Spanish Lung Cancer Group

Completed

Re-challenge Pembrolizumab Study as a Second or Further Line in Patients With Advanced NSCLC (Replay)

Lung Cancer

Spain
Spanish Lung Cancer Group

Completed

Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis (ATEZO-BRAIN)

Non-small Cell Lung Cancer Stage IV

Spain
Spanish Lung Cancer Group

Completed

LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID) (GRAVID)

Covid-19 | Lung Cancer

Spain
Spanish Lung Cancer Group

Completed

Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer (NATCH)

Non-Small-Cell Lung Cancer
Spanish Lung Cancer Group

Completed

Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR (EURTAC)

Non-Small Cell Lung Cancer

Spain, France, Italy
Spanish Lung Cancer Group

Completed

Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced Adenocarcinoma (SLAT)

Non-small Cell Lung Cancer

Spain
Spanish Lung Cancer Group

Completed

Durvalumab in Solid Tumors

Cancer | HIV

Spain
Spanish Lung Cancer Group

Completed

T790M Mutation Testing in Blood by Different Methodologies

NSCLC Stage IV

Spain
Spanish Lung Cancer Group

Completed

Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient (NIVEX)

Non Small Cell Lung Cancer

Spain
Spanish Lung Cancer Group

Completed

Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients

Non Small Cell Lung Cancer

Spain
Spanish Lung Cancer Group

Active, not recruiting

Pembrolizumab in Elderly Patients With Advanced Lung Cancer

Non Small Cell Lung Cancer

Spain
Spanish Lung Cancer Group

Completed

Analysis of Soluble Mediators,Cytokines and FACs as Prognostic Factors in Advanced Non-squamous Lung Carcinoma

Non-small Cell Lung Cancer

Spain
Spanish Lung Cancer Group

Completed

Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone (GOAL)

Non Small Cell Lung Cancer

Spain
Spanish Lung Cancer Group

Terminated

Study of Pemetrexed Plus Cisplatin as First-line Therapy in Patients With Advanced Non-squamous NSCLC (Phalcis)

Carcinoma, Non Small Cell Lung

Spain
Spanish Lung Cancer Group

Terminated

Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS

Non Small Cell Lung Cancer

Spain
Spanish Lung Cancer Group

Terminated

Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung Carcinoma (BREC)

Non Small Cell Lung Cancer | BRCA1 Mutation

Spain
Spanish Lung Cancer Group

Completed

Study of Vinorelbine and Cisplatin as Induction Therapy With Radiotherapy in Patients With Unresectable NSCLC (NORA)

Lung Cancer

Spain
Spanish Lung Cancer Group

Completed

Randomized Customized Adjuvant Chemotherapy (GECP-SCAT) (GECP-SCAT)

Non-small-cell Lung Cancer

Spain
Spanish Lung Cancer Group

Completed

Observational Post-authorization Studies Carboplatin, Paclitaxel and Bevacizumab (ANGIOMET)

Nonsquamous Nonsmall Cell Neoplasm of Lung

Spain
Regional Hospital West Jutland
Danish Cancer Society; Danish Lung Cancer Group

Completed

Feasibility of a Web-based Patient Reported Outcome Symptom Monitoring Application in Danish Lung Cancer Patients

Lung Cancer Stage IV

Denmark
Regional Hospital West Jutland
Danish Cancer Society; Danish Lung Cancer Group

Completed

Intensified Follow-up of Lung Cancer Using Weekly Questionnaires Via the Internet (ProWide)

Lung Cancer

Denmark
Spanish Lung Cancer Group
Aventis Pharmaceuticals

Completed

Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer (GECP0008)

Non Small-cell Lung Cancer
Rigshospitalet, Denmark
Aarhus University Hospital; Danish Lung Cancer Group

Completed

Chronic Pain After Thoracotomy, an Incidence Study

Chronic Pain | Thoracotomy

Denmark
Danish Breast Cancer Cooperative Group
Danish Cancer Society

Active, not recruiting

Hypofractionated Versus Standard Fractionated Whole Breast Irradiation to Node-negative Breast Cancer Patients

Breast Cancer | Carcinoma in Situ of the Breast

Denmark
Danish Breast Cancer Cooperative Group
Danish Cancer Society

Active, not recruiting

Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated Boost

Fibrosis | Lymphedema

Denmark
ETOP IBCSG Partners Foundation
Spanish Lung Cancer Group

Completed

BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC) (BELIEF)

Lung Cancer

Spain, Ireland, United Kingdom, Switzerland, France, Germany, Greece, Italy
University of Cologne
Pfizer; Spanish Lung Cancer Group

Completed

EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung Cancer (EUCROSS)

Adenocarcinoma | NSCLC | Lung Cancer

Germany, Spain, Switzerland
Spanish Lung Cancer Group
Merck Sharp & Dohme LLC

Terminated

Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.

Non-small Cell Lung Cancer

Spain
Danish Breast Cancer Cooperative Group

Recruiting

The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer

Early Breast Cancer | Radiation Associated Cardiac Failure

Denmark
Danish Breast Cancer Cooperative Group

Recruiting

Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy

Breast Neoplasm Female | Breast Implant; Complications | Complication of Radiation Therapy

Denmark
Danish Breast Cancer Cooperative Group

Unknown

National Screening in Denmark With MR Versus Mammography and Ultrasound of Women With BRCA1 or BRCA2 Mutations (MR BRCA)

Breast Cancer

Denmark
Rigshospitalet, Denmark
Danish Cancer Society; Danish Breast Cancer Cooperative Group

Completed

Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms

Breast Cancer | Lymphedema | Neuropathic Pain | Neuropathy | Persistent Pain

Denmark
Danish Lung Cancer Group
Ministry of the Interior and Health, Denmark

Unknown

Danish Lung Cancer Screening Trial (DLCST) (DLCST)

Lung Cancer

Denmark
Lund University Hospital
Danish Breast Cancer Cooperative Group; Swedish Breast Cancer Group; Finnish... and other collaborators

Recruiting

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Breast Cancer | Triple Negative Breast Neoplasms

Denmark, Sweden
Lung Cancer Group Cologne

Terminated

FGFR Inhibitor in FGFR Dysregulated Cancer (FIND)

NSCLC | Lung Cancer | NSCLC Stage IV | Squamous Cell Lung Cancer | Pulmonary Neoplasm

Germany
Lung Cancer Group Cologne

Unknown

Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC) (ERLOPET)

Carcinoma, Non-Small-Cell Lung

Germany
Rigshospitalet, Denmark
Danish Cancer Society; Danish Breast Cancer Cooperative Group

Unknown

Chronic Pain After Operation for Breast Cancer

Pain Threshold

Denmark
Danish Head and Neck Cancer Group

Recruiting

DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC. (DAHANCA30)

Hypoxia | Head and Neck Squamous Cell Carcinoma | Radiotherapy | Hypoxic Modification | Gene Profile, Gene Signature

Denmark
Danish Head and Neck Cancer Group

Active, not recruiting

DAHANCA 27 Transoral Laser Microsurgery for T1a Glottic Cancer (DAHANCA 27)

Head and Neck Squamous Cell Carcinoma | Glottic T1

Denmark
Danish Head and Neck Cancer Group

Completed

DAHANCA 28A: Phase I/II Study on Accelerated, Hyperfractionated Radiotherapy With Concomitant Cisplatin and Nimorazole

HNSCC,Larynx, Pharynx and Oral Cavity

Denmark
Danish Head and Neck Cancer Group

Recruiting

DAHANCA 37. Re-irradiation With Proton Radiotherapy

Head and Neck Neoplasms

Denmark
Danish Head and Neck Cancer Group

Unknown

DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC

Radiotherapy | Locally Advanced Head and Neck Cancer | Hypoxic Radioresistance

Denmark
Danish Head and Neck Cancer Group

Completed

DAHANCA 25B: Progressive Resistance Training as Intervention for Regaining Muscle Mass After Radiation Therapy in Patients With HNSCC

Head and Neck Cancer

Denmark
Bispebjerg Hospital
Danish Cancer Society; Nordic Cancer Union; Danish Colorectal Cancer Group

Unknown

Assessment of Frequency of Surveillance After Curative Resection in Patients With Stage II and III Colorectal Cancer

Colorectal Cancer

Denmark
Danish Head and Neck Cancer Group

Active, not recruiting

Feasibility of Patient Selection and Treatment of Head-neck Cancer With Proton Therapy in Denmark

Head-and-neck Cancer

Denmark
Danish Head and Neck Cancer Group

Completed

DAHANCA 19: The Importance of the EGFr-inhibitor Zalutumumab for the Outcome After Curative Radiotherapy for HNSCC

Cancer of the Head and Neck

Denmark
Danish Breast Cancer Cooperative Group
Novartis; Danish Cancer Society; The Danish Medical Research Council

Terminated

Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer (REAL)

Operable Breast Neoplasms

Denmark

Clinical Trials Sponsored by Danish Oncological Lung Cancer Group

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations